Regeneron Pharmaceuticals, Inc.
Use of LEPR Agonists for Pain

Abstract:

The present invention provides methods for reducing pain, the use of opioids and hospitalization in patients suffering with a leptin deficiency or leptin resistance condition such as lipodystrophy. There may be implications of this invention in other forms of chronic pain that involves centralization or hypersensitization of pain by the central nervous system.